Terms: = Ovarian cancer AND IL7R, P16871, IL-7R-alpha, CDW127, CD127, ENSG00000168685, 3575
17 results:
1. Effect of Peripheral Blood Lymphocytes on Prognosis of Multiple cancers.
Zhang X; Jing J
Cancer Control; 2023; 30():10732748231202921. PubMed ID: 37815060
[TBL] [Abstract] [Full Text] [Related]
2. Peripheral lymphocyte populations in ovarian cancer patients and correlations with clinicopathological features.
Ye S; Chen W; Zheng Y; Wu Y; Xiang L; Li T; Ping B; Zhang X; Yang H
J Ovarian Res; 2022 Apr; 15(1):43. PubMed ID: 35410290
[TBL] [Abstract] [Full Text] [Related]
3. Overexpression of
Jiang S; Yang Y; Zhang Y; Ye Q; Song J; Zheng M; Li X
Dis Markers; 2022; 2022():9719671. PubMed ID: 35186171
[TBL] [Abstract] [Full Text] [Related]
4. Computational studies reveal co-occurrence of two mutations in il7r gene of high-grade serous carcinoma patients.
Wadapurkar RM; Sivaram A; Vyas R
J Biomol Struct Dyn; 2022; 40(23):13310-13324. PubMed ID: 34657565
[TBL] [Abstract] [Full Text] [Related]
5. Plasma levels and tissue expression of soluble TGFβrIII receptor in women with early-stage breast cancer and in healthy women: a prospective observational study.
Grgurevic L; Novak R; Trkulja V; Hrkac S; Salai G; Bilandzic J; Hamzic LF; Milas I; Vucemilo T; Balja MP; Bilic K
J Transl Med; 2020 Dec; 18(1):478. PubMed ID: 33308241
[TBL] [Abstract] [Full Text] [Related]
6. Immune correlates of clinical benefit in a phase I study of hyperthermia with adoptive T cell immunotherapy in patients with solid tumors.
Qiao G; Wang X; Zhou X; Morse MA; Wu J; Wang S; Song Y; Jiang N; Zhao Y; Zhou L; Zhao J; Di Y; Zhu L; Hobeika A; Ren J; Lyerly HK
Int J Hyperthermia; 2019 Nov; 36(sup1):74-82. PubMed ID: 31795830
[No Abstract] [Full Text] [Related]
7. A systematic review of risk-reducing cancer surgery outcomes for hereditary cancer syndromes.
Peacock O; Waters PS; Otero de Pablos J; Boussioutas A; Skandarajah A; Simpson JA; Warrier SK; Heriot AG
Eur J Surg Oncol; 2019 Dec; 45(12):2241-2250. PubMed ID: 31262600
[TBL] [Abstract] [Full Text] [Related]
8. Follicular regulatory T cells infiltrated the ovarian carcinoma and resulted in CD8 T cell dysfunction dependent on IL-10 pathway.
Li L; Ma Y; Xu Y
Int Immunopharmacol; 2019 Mar; 68():81-87. PubMed ID: 30616170
[TBL] [Abstract] [Full Text] [Related]
9. Targeting cytokines secreted by CD4
Ke X; Shen L
Scand J Immunol; 2019 Feb; 89(2):e12736. PubMed ID: 30485902
[TBL] [Abstract] [Full Text] [Related]
10. Male BRCA mutation carriers: clinical characteristics and cancer spectrum.
Ibrahim M; Yadav S; Ogunleye F; Zakalik D
BMC Cancer; 2018 Feb; 18(1):179. PubMed ID: 29433453
[TBL] [Abstract] [Full Text] [Related]
11. THE PROGNOSTIC SIGNIFICANCE OF P53, BCL2 AND MIB1 EXPRESSIONS RELATED WITH OTHER CLINICOPATHOLOGICAL VARIABLES IN SEROUS ovarian CARCINOMAS. A CLINICOPATHOLOGICAL STUDY IN PERITONEAL FLUIDS.
Kalogeraki A; Tamiolakis D; Matalliotaki C; Karvela-Kalogeraki I; Karvelas-Kalogerakis M; Segredakis J; Sinatkas V; Matalliotakis I
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):454-60. PubMed ID: 26204652
[TBL] [Abstract] [Full Text] [Related]
12. Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry.
Santegoets SJ; Dijkgraaf EM; Battaglia A; Beckhove P; Britten CM; Gallimore A; Godkin A; Gouttefangeas C; de Gruijl TD; Koenen HJ; Scheffold A; Shevach EM; Staats J; Taskén K; Whiteside TL; Kroep JR; Welters MJ; van der Burg SH
Cancer Immunol Immunother; 2015 Oct; 64(10):1271-86. PubMed ID: 26122357
[TBL] [Abstract] [Full Text] [Related]
13. PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human ovarian cancer.
Webb JR; Milne K; Nelson BH
Cancer Immunol Res; 2015 Aug; 3(8):926-35. PubMed ID: 25957117
[TBL] [Abstract] [Full Text] [Related]
14. Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study.
Shebl FM; Sakoda LC; Black A; Koshiol J; Andriole GL; Grubb R; Church TR; Chia D; Zhou C; Chu LW; Huang WY; Peters U; Kirsh VA; Chatterjee N; Leitzmann MF; Hayes RB; Hsing AW
Br J Cancer; 2012 Jun; 107(1):207-14. PubMed ID: 22722313
[TBL] [Abstract] [Full Text] [Related]
15. Suppressive activity rather than frequency of FoxP3(+) regulatory T cells is essential for CA-125-specific T-cell activation after abagovomab treatment.
Reinartz S; Pfisterer J; du Bois A; Jackisch C; Baumann KH; Wagner U
Hum Immunol; 2010 Jan; 71(1):36-44. PubMed ID: 19782714
[TBL] [Abstract] [Full Text] [Related]
16. Free interferon-alpha/beta receptors in the circulation of patients with adenocarcinoma.
Ambrus JL; Dembinski W; Ambrus JL; Sykes DE; Akhter S; Kulaylat MN; Islam A; Chadha KC
Cancer; 2003 Dec; 98(12):2730-3. PubMed ID: 14669296
[TBL] [Abstract] [Full Text] [Related]
17. High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer.
Anttila MA; Tammi RH; Tammi MI; Syrjänen KJ; Saarikoski SV; Kosma VM
Cancer Res; 2000 Jan; 60(1):150-5. PubMed ID: 10646867
[TBL] [Abstract] [Full Text] [Related]
